ArticleCancer treatment and research communications2021

Safe and effective use of nivolumab plus ipilimumab in a patient with metastatic clear-cell renal cell carcinoma with sarcomatoid dedifferentiation and end stage renal disease on hemodialysis.

Leah K Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.